The ACMG Foundation for Genetic and Genomic Medicine will award the David L. Rimoin Inspiring Excellence Award to a selected student, trainee, or junior faculty ACMG member whose abstract submission in the Clinical Genetics and Therapeutics category is chosen as a platform presentation during the 2027 ACMG Annual Clinical Genetics Meeting. In recognition of their selected presentation, the Rimoin Fund will provide a cash award of $1,000 and registration, travel and 3 nights’ accommodation to attend the meeting.
How to be considered for the David L. Rimoin Inspiring Excellence Award:
- All ACMG member geneticists-in-training, who are both first author and presenter of the abstract in the Clinical Genetics and Therapeutics category, are considered for an Abstract Award. You must identify as a geneticist–in–training and then select the appropriate training category (undergraduate student, medical student, graduate student, resident physician, or post-doctoral fellow) in the online abstract submission system.
- As a geneticist–in–training, you are required to submit a letter from the senior investigator overseeing your research confirming your status as a geneticist-in-training. The deadline for receipt of the geneticist-in-training letter is November 13, 2026. There will be no exceptions.
- Your letter must be typed on your institution’s letterhead, signed by the senior investigator, saved in PDF format, and uploaded to the online abstract submission system.
- Please include the following items in your letter: Author name (this is the geneticist-in-training who is the presenting/contact author); Confirmation of your status as a geneticist-in-training
- Abstract Award recipients will be notified December 16-18, 2026. You must register for and attend the meeting and present your abstract to receive your award.
Eligible candidates interested in entering the competition will indicate so during the abstract submission process.